Attenuation of oxidative stress and cardioprotective effects of zinc supplementation in experimental diabetic rats.

Keywords : ["experimental diabetic rat", "zinc supplementation", "oxidative stress", "cardioprotective effect", "attenuation"]
Author : Fist_Author_Year_PM
48

Efficacy and safety of once-weekly semaglutide versus once-daily sitagliptin as an add-on to metformin, thiazolidinediones, or both, in patients with type 2 diabetes (SUSTAIN 2): a 56-week, double-blind, phase 3a, randomised trial.

Keywords : ["onceweekly semaglutide versus oncedaily sitagliptin", "doubleblind phase randomise trial", "type diabetes sustain", "metformin thiazolidinedione", "safety", "patient", "efficacy", "addon"]
Author : Fist_Author_Year_PM
95

Obstructive sleep apnoea and Type 2 diabetes mellitus: are they connected?

Keywords : ["type diabetes mellitus", "obstructive sleep apnoea", "connect"]
Author : Fist_Author_Year_PM
9

Drug addiction and diabetes: South Asian action.

Keywords : ["diabetes south asian action", "drug addiction"]
Author : Fist_Author_Year_PM
35

Impact of diet restriction in the management of diabetes: evidences from preclinical studies.

Keywords : ["preclinical study", "diet restriction", "diabetes evidence", "management", "impact"]
Author : Fist_Author_Year_PM
49

Multinational Consensus: Insulin Initiation with Insulin Degludec/Aspart (IDegAsp).

Keywords : ["multinational consensus insulin initiation", "insulin degludecaspart idegasp"]
Author : Fist_Author_Year_PM
51

Treatment of 'Diabesity': Beyond Pharmacotherapy.

Keywords : ["diabesity beyond pharmacotherapy", "treatment"]
Author : Fist_Author_Year_PM
68

Morus alba Leaf Bioactives Modulate Peroxisome Proliferator Activated Receptor gamma in the Kidney of Diabetic Rat and Impart Beneficial Effect.

Keywords : ["morus alba leaf bioactive modulate peroxisome proliferator activate receptor gamma", "impart beneficial effect", "diabetic rat", "kidney"]
Author : Fist_Author_Year_PM
36

Cardiovascular safety of oral semaglutide in patients with type 2 diabetes: Rationale, design and patient baseline characteristics for the PIONEER 6 trial.

Keywords : ["type diabetes rationale design", "patient baseline characteristic", "pioneer trial", "oral semaglutide", "cardiovascular safety", "patient"]
Author : Fist_Author_Year_PM
102

Evaluation of anti-diabetic attributes of Lactobacillus rhamnosus MTCC: 5957, Lactobacillus rhamnosus MTCC: 5897 and Lactobacillus fermentum MTCC: 5898 in streptozotocin induced diabetic rats.

Keywords : ["lactobacillus rhamnosus mtcc lactobacillus rhamnosus mtcc", "streptozotocin induce diabetic rat", "lactobacillus fermentum mtcc", "antidiabetic attribute", "evaluation"]
Author : Fist_Author_Year_PM
64